EA200500213A1 - Диспергируемые таблетки для орального назначения - Google Patents

Диспергируемые таблетки для орального назначения

Info

Publication number
EA200500213A1
EA200500213A1 EA200500213A EA200500213A EA200500213A1 EA 200500213 A1 EA200500213 A1 EA 200500213A1 EA 200500213 A EA200500213 A EA 200500213A EA 200500213 A EA200500213 A EA 200500213A EA 200500213 A1 EA200500213 A1 EA 200500213A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oral
appointment
dispensable tablets
dispensable
tablets
Prior art date
Application number
EA200500213A
Other languages
English (en)
Inventor
Шашикант Излоор
Шишир Бханд
Суниленду Бхушан Рой
Раджив Малик
Original Assignee
Рэнбакси Лабораториз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рэнбакси Лабораториз Лимитед filed Critical Рэнбакси Лабораториз Лимитед
Publication of EA200500213A1 publication Critical patent/EA200500213A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Abstract

Настоящее изобретение относится к способу получения диспергируемой таблетированной лекарственной формы, включающей β-лактамный антибиотик для орального назначения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500213A 2002-07-16 2003-07-16 Диспергируемые таблетки для орального назначения EA200500213A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN753DE2002 2002-07-16
PCT/IB2003/002817 WO2004006917A1 (en) 2002-07-16 2003-07-16 Dispersible tablets for oral administration

Publications (1)

Publication Number Publication Date
EA200500213A1 true EA200500213A1 (ru) 2005-08-25

Family

ID=30012265

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500213A EA200500213A1 (ru) 2002-07-16 2003-07-16 Диспергируемые таблетки для орального назначения

Country Status (10)

Country Link
US (1) US20060110445A1 (ru)
EP (1) EP1539146A1 (ru)
KR (1) KR20050062514A (ru)
CN (1) CN1681497A (ru)
AU (1) AU2003249116A1 (ru)
BR (1) BR0312728A (ru)
EA (1) EA200500213A1 (ru)
MX (1) MXPA05000641A (ru)
WO (1) WO2004006917A1 (ru)
ZA (1) ZA200501084B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21912A (sl) * 2004-12-24 2006-06-30 Lek Farmacevtska Druzba D.D. Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same
TR201002878A2 (tr) * 2010-04-13 2011-10-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil içeren farmasötik bileşimler.
WO2011152808A1 (en) * 2010-06-03 2011-12-08 Mahmut Bilgic Formulation comprising cefpodoxime proxetil and clavulanic acid
TR201007107A1 (tr) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.
TR201007106A1 (tr) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil formülasyonları.
TR201009168A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Suda dağılan sefpodoksim proksetil formülasyonları.
TR201010860A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir formulasyonları için üretim yöntemi.
TR201009167A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefalosporin içeren farmasötik granüller.
WO2013001541A1 (en) * 2011-06-30 2013-01-03 Aggarwal Kumar Vijay An optimized bilayered tablet dosage form with high rate of bioavailability of two active antibiotics: cefuroxime and clavulanic acid
WO2013001543A1 (en) * 2011-06-30 2013-01-03 Aggarwal Kumar Vijay An optimized bilayered tablet dosage form with two active antibiotics: clavulanic acid and cefpodoxime
CN102488668A (zh) * 2011-12-29 2012-06-13 山东淄博新达制药有限公司 头孢呋辛酯分散片剂及其制备方法
CN102697747A (zh) * 2012-06-13 2012-10-03 广州南新制药有限公司 一种头孢呋辛酯的分散片
EP2882423A1 (en) * 2012-08-07 2015-06-17 Sandoz AG Uncoated tablet comprising granules including a -lactam antibiotic and highly dispersed silicone dioxide
CN103340855B (zh) * 2013-07-16 2015-01-07 上海汉维生物医药科技有限公司 复方阿莫西林克拉维酸钾片剂及其制备方法
CN104473922B (zh) * 2013-07-16 2018-05-01 上海汉维生物医药科技有限公司 复方片剂及其制备方法
CN104546838B (zh) * 2013-07-16 2018-05-01 上海汉维生物医药科技有限公司 片剂及其制备方法
EP3068227A4 (en) * 2013-11-11 2017-06-21 Forest Laboratories Holdings Limited Compositions and methods of treatment comprising fosfomycin disodium
CN104257618B (zh) * 2014-09-26 2017-01-11 山东新时代药业有限公司 一种含有法罗培南钠的口腔崩解片及其制备方法
CN113398083A (zh) * 2021-06-24 2021-09-17 山东淄博新达制药有限公司 一种头孢呋辛酯分散片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552416A (en) * 1975-08-12 1979-09-12 Beecham Group Ltd Pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6361794B1 (en) * 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
IL131201A (en) * 1997-02-14 2005-06-19 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxycillin and clavulanate
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
CA2433962C (en) * 2002-07-19 2012-10-30 Abbott Laboratories Antibacterial clarithromycin compositions and processes for making the same

Also Published As

Publication number Publication date
MXPA05000641A (es) 2005-04-19
KR20050062514A (ko) 2005-06-23
ZA200501084B (en) 2006-03-29
BR0312728A (pt) 2005-04-26
WO2004006917A1 (en) 2004-01-22
EP1539146A1 (en) 2005-06-15
CN1681497A (zh) 2005-10-12
US20060110445A1 (en) 2006-05-25
AU2003249116A1 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
EA200500213A1 (ru) Диспергируемые таблетки для орального назначения
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
TW200503784A (en) Organic compounds
NO20053150D0 (no) System for administrasjon av medisin.
SI1689370T2 (sl) Postopek za pripravo trdnega, oralno uporabnega farmacevtskega sestavka, ki obsega 5-klor-N(((5S)-2okso-3-(4-(3-okso-4-morfolinil)-fenil)-1,3-oksazolidin -5-il)-metil)-2-tiofenkarboksamid
NO20052158L (no) Fremgangsmate for fremstilling av en benzimidazolforbindelse.
NO20064808L (no) Orale matrixformuleringer med licarbazepin
TNSN05233A1 (en) Oral pharmaceutical preparation comprising a proton pump antagonist and a basic exipient
NO20064783L (no) Opplosningstabeletter med licarbazepin
HUP0402488A3 (en) Compressed oral pharmaceutical dosage form, with an enteric coating, which contains an acid-labile benzimidazole compound
IL174009A0 (en) Melt-formulated, multi-particulate oral dosage form
FR2842524B1 (fr) Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments
WO2004043900A3 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
ITMI20032523A1 (it) Forma di dosaggio per uso orale comprendente un farmaco
FR2842526B1 (fr) Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments
WO2005051349A3 (en) Pharmaceutical compositions of mirtazapine
EP1580191A4 (en) PROCESS FOR PRODUCING CARBAPENEM COMPOUND FOR ORAL ADMINISTRATION
PL359727A1 (en) Crystalline pharmaceutical
AU1022201A (en) Novel LTB4 antagonist, method for the production thereof and its use as a medicament
HK1057368A1 (en) New indoline compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200308265B (en) Imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them.
ITRM20010367A1 (it) Gruppo alimentatore di capsule per macchine capsulatrici.
PL375142A1 (en) Transmucosal pharmaceutical administration form